| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Investing > Real Estate Investing - The Number One Mistake |
|
Top Articles - Real Estate Investing - The Number One Mistake
There are a lot of mistakes that beginning real estate investors can make. But there is one mistake that is by According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product far the most common. The number one mistake made by beginning investors is failing to take action. As you atte ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in d the real estate investor’s club meetings and seminars you’ll notice a lot of the same people all the time. A lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. majority of those people aren’t investors yet. They are still trying to get started. They are beginners. And, here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe some of them have been beginners for years. They attend seminar after seminar. They read book after book abou d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro investing. They attend meeting after meeting. They have accumulated a lot of “head knowledge”. The problem ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc s they are making the most common mistake of all. They have failed to take action. If you come back a year fr easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi m now most of those people will be right where they are today. I implore you to take a vow to avoid this mista nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically e. There is simply no substitute for action. Even if it’s a mistake. Just do something. Your goal should be and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ to purchase your first property within the first 90 days. There is no reason that you can’t accomplish this go ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi l. Take action. Take action every day. Don’t let a single day go by without taking some sort of action. Mak ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a e a list of 10 things, 20 things, or 100 things you must do to get started. Then take action everyday to accom dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod lish those things. Move forward toward purchasing your first property, then your second, and third, etc. Thom cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin s Edison is known for his wonderful inventions and probably best known for inventing the incandescent light bul tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen . He worked on it for years and failed thousands of times. At one point after suffering thousands of setbacks t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel and failures he was asked, “What keeps you from giving up?” He replied, “Why would I give up. I haven’t failed ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust I know a 1000 ways that don’t work.” Don’t be afraid to take action. Don’t be afraid to make mistakes. Some y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products of your greatest achievements will be borne out of the mistakes you make. I’ve talked with hundreds of investo . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de s and NO ONE has ever said, “I wish I had waited longer before taking action.” No one has ever said, “I wish I elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip had done less.” Without fail, every one of them said, “I wish I had started sooner and bought more properties. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Weak Link of Lean Manufacturing Accounts Receivable Factoring- An Alternative to Bank Financing
|